Beyond THC and Endocannabinoids.

Pacher, Pal; Kogan, Natalya M; Mechoulam, Raphael

Pacher, Pal; Kogan, Natalya M; Mechoulam, Raphael.

Afiliación

Pacher P; Laboratory of Cardiovascular Physiology and Tissue Injury and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20852, USA; email: ppacher@gmail.com.
Kogan NM; Institute for Drug Research, Faculty of Medicine, Hebrew University, Jerusalem 9112102, Israel; email: raphaelm@ekmd.huji.ac.il.
Mechoulam R; Institute for Drug Research, Faculty of Medicine, Hebrew University, Jerusalem 9112102, Israel; email: raphaelm@ekmd.huji.ac.il.

Annu Rev Pharmacol Toxicol ; 60: 637-659, 2020 01 06.

Article en En | MEDLINE | ID: mdl-31580774

Asunto(s)

Cannabinoides/farmacología; Dronabinol/farmacología; Endocannabinoides/metabolismo; Animales; Ácidos Araquidónicos/metabolismo; Agonistas de Receptores de Cannabinoides/farmacología; Glicéridos/metabolismo; Humanos; Alcamidas Poliinsaturadas/metabolismo

Palabras clave

anandamide; cannabidiol; cannabinoid receptors; entourage effect; long-chain fatty acid amides

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dronabinol / Cannabinoides / Endocannabinoides Límite: Animals / Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google